(Q73911856)

English

Molecular remission induced by gemtuzumab ozogamicin associated with donor lymphocyte infusions in t(4;11) acute lymphoblastic leukemia relapsed after transplantation

scientific article published on 01 November 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12960967%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Molecular remission induced by gemtuzumab ozogamicin associated with donor lymphocyte infusions in t(4;11) acute lymphoblastic leukemia relapsed after transplantation (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12960967%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

Adriana Balduzzi

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12960967%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

Vincenzo Rossi

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12960967%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Lilia Corral

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12960967%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Sonia Bonanomi

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12960967%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Daniela Longoni

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12960967%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Attilio Rovelli

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12960967%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Valentino Conter

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12960967%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Andrea Biondi

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12960967%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Cornelio Uderzo

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12960967%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

publication date

1 November 2003

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12960967%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12960967%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12960967%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12960967%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

2247-2248

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12960967%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

https://scigraph.springernature.com/pub.10.1038/sj.leu.2403134

0 references

Treatment of leukemic relapse after allogeneic stem cell transplantation with cytotoreductive chemotherapy and/or immunotherapy or second transplants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403134

7 January 2021

based on heuristic

inferred from DOI database lookup

Donor leukocyte infusions in acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403134

7 January 2021

based on heuristic

inferred from DOI database lookup

Results of minimal residual disease (MRD) evaluation and MRD-based treatment stratification in childhood ALL.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403134

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of relapse after allogeneic bone marrow transplantation with reduced intensity conditioning (FLAG +/- Ida) and second allogeneic stem cell transplant.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403134

7 January 2021

based on heuristic

inferred from DOI database lookup

Gemtuzumab ozogamicin in pediatric CD33-positive acute lymphoblastic leukemia: first clinical experiences and relation with cellular sensitivity to single agent calicheamicin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403134

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatic sinusoidal obstruction after gemtuzumab ozogamicin (Mylotarg) therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403134

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73911856&oldid=2098559019"